SAB Biotherapeutics (NASDAQ:SABS) reported its Q1 earnings results on Tuesday, May 16, 2023 at 08:30 AM.
Here’s what investors need to know about the announcement.
Earnings
SAB Biotherapeutics missed estimated earnings by 87.5%, reporting an EPS of $-0.15 versus an estimate of $-0.08.
Revenue was down $11.22 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.15 which was followed by a 4.4% drop in the share price the next day.
Listen to the earnings announcement yourself by clicking here.
To track all earnings releases for SAB Biotherapeutics visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
